Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1950 2
1951 3
1953 1
1954 2
1955 3
1956 3
1957 3
1958 4
1959 7
1960 6
1961 7
1962 12
1963 17
1964 19
1965 22
1966 33
1967 24
1968 29
1969 24
1970 26
1971 25
1972 38
1973 38
1974 52
1975 40
1976 52
1977 42
1978 55
1979 56
1980 56
1981 58
1982 95
1983 83
1984 122
1985 126
1986 128
1987 143
1988 156
1989 148
1990 160
1991 145
1992 160
1993 169
1994 173
1995 224
1996 198
1997 192
1998 232
1999 244
2000 273
2001 228
2002 241
2003 219
2004 247
2005 267
2006 279
2007 296
2008 318
2009 316
2010 337
2011 329
2012 386
2013 449
2014 405
2015 393
2016 402
2017 399
2018 429
2019 511
2020 590
2021 607
2022 555
2023 506
2024 517
2025 517
2026 79

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,578 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean oyamada t[au] (144 results)?
Dual regulation of mitochondrial fusion by Parkin-PINK1 and OMA1.
Yamada T, Ikeda A, Murata D, Wang H, Zhang C, Khare P, Adachi Y, Ito F, Quirós PM, Blackshaw S, López-Otín C, Langer T, Chan DC, Le A, Dawson VL, Dawson TM, Iijima M, Sesaki H. Yamada T, et al. Nature. 2025 Mar;639(8055):776-783. doi: 10.1038/s41586-025-08590-2. Epub 2025 Feb 19. Nature. 2025. PMID: 39972141 Free PMC article.
Metamaterial robotics.
Zheng X, Jiang Y, Mete M, Li J, Watanabe I, Yamada T, Paik J. Zheng X, et al. Among authors: yamada t. Sci Robot. 2025 Nov 19;10(108):eadx1519. doi: 10.1126/scirobotics.adx1519. Epub 2025 Nov 19. Sci Robot. 2025. PMID: 41259447 Review.
Oncogene aberrations drive medulloblastoma progression, not initiation.
Okonechnikov K, Joshi P, Körber V, Rademacher A, Bortolomeazzi M, Mallm JP, Vaillant J, da Silva PBG, Statz B, Sepp M, Sarropoulos I, Yamada T, Wittmann A, Schramm K, Blattner-Johnson M, Fiesel P, Jones B, Jäger N, Milde T, Pajtler KW, van Tilburg CM, Witt O, Bochennek K, Weber KJ, Nonnenmacher L, Reimann C, Ghasemi DR, Schüller U, Mynarek M, Rutkowski S, Jones DTW, Korshunov A, Rippe K, Westermann F, Thongjuea S, Höfer T, Kaessmann H, Kutscher LM, Pfister SM. Okonechnikov K, et al. Among authors: yamada t. Nature. 2025 Jun;642(8069):1062-1072. doi: 10.1038/s41586-025-08973-5. Epub 2025 May 7. Nature. 2025. PMID: 40335697 Free PMC article.
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results.
Liu N, Wu J, Deng E, Zhong J, Wei B, Cai T, Xie Z, Duan X, Fu S, Osei-Hwedieh DO, Huang K, Zhuang P, Sha O, Chen Y, Lv X, Zhu Y, Zhang L, Lin H, Li Q, Lu P, Miao J, Yamada T, Cai L, Du H, Baca SC, Huang Q, Ferrone S, Wang X, Xu F, Fan X, Fan S. Liu N, et al. Among authors: yamada t. Nat Med. 2025 Sep;31(9):3047-3061. doi: 10.1038/s41591-025-03873-7. Epub 2025 Aug 25. Nat Med. 2025. PMID: 40855191 Clinical Trial.
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial.
Masuda M, Sunaga A, Tanaka N, Watanabe T, Minamiguchi H, Egami Y, Oka T, Minamisaka T, Kanda T, Okada M, Kawasaki M, Matsuda Y, Tanaka K, Yamada T, Hikoso S, Dohi T, Inoue K, Sotomi Y, Sakata Y; OCVC-SUPPRESS-AF investigators. Masuda M, et al. Among authors: yamada t. Nat Med. 2025 May;31(5):1661-1667. doi: 10.1038/s41591-025-03674-y. Epub 2025 Apr 30. Nat Med. 2025. PMID: 40307511 Free PMC article. Clinical Trial.
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling.
Murakami M, Naruse M, Kobayashi H, Parasiliti-Caprino M, Bioletto F, Brüdgam D, Stüfchen I, Reincke M, St-Jean M, Kraljevic I, Kastelan D, Nevalainen PI, Araujo-Castro M, Sukor N, Nijhoff MF, Matrozova J, Ragnarsson O, Shafigullina Z, Matikainen N, Markou A, Piaditis G, Izawa S, Katabami T, Ichijo T, Tanabe A, Tsuiki M, Kakutani M, Wada N, Masuda S, Bacca AV, Beuschlein F, Maiolino G, Falhammar H, Grytaas MA, Løvås K, Almeida MQ, Furnica RM, Puar T, Kmieć P, Masi S, Bourdeau I, Amar L, Dennedy MC, Fallo F, Deinum J, O'Toole S, Yamada T, Quinkler M, Lacroix A, Kocjan T. Murakami M, et al. Among authors: yamada t. Eur J Endocrinol. 2025 Jun 30;193(1):85-96. doi: 10.1093/ejendo/lvaf117. Eur J Endocrinol. 2025. PMID: 40485198
Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry.
Nakamura M, Kuriyama N, Tanaka Y, Yamazaki S, Kawasaki T, Muramatsu T, Kadota K, Ashikaga T, Takahashi A, Otsuji S, Ando K, Ishida M, Nakamura S, Ito Y, Iijima R, Nakazawa G, Shite J, Honye J, Ako J, Yokoi H, Kozuma K, Otake H, Masumura K, Yamada T, Sotomi Y. Nakamura M, et al. Among authors: yamada t. Cardiovasc Interv Ther. 2025 Jul;40(3):553-564. doi: 10.1007/s12928-025-01130-9. Epub 2025 May 12. Cardiovasc Interv Ther. 2025. PMID: 40354027 Free PMC article.
Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial.
Watanabe S, Nakayama M, Yokoo T, Sanada S, Ubara Y, Komatsuda A, Asanuma K, Suzuki Y, Konta T, Kazama JJ, Suzuki T, Fukuda S, Soga T, Yamada T, Mizutani S, Matsumoto M, Naito Y, Taguchi K, Fukami K, Kashiwagi H, Kikuchi K, Suzuki C, Tokuno H, Urasato M, Kujirai R, Matsumoto Y, Akiyama Y, Tomioka Y, Itai S, Tongu Y, Mishima E, Kawabe C, Kasahara T, Ogata Y, Toyohara T, Sato T, Tanaka T, Abe T; LUBI-CKD TRIAL Investigators. Watanabe S, et al. Among authors: yamada t. Sci Adv. 2025 Aug 29;11(35):eadw3934. doi: 10.1126/sciadv.adw3934. Epub 2025 Aug 29. Sci Adv. 2025. PMID: 40880481 Free PMC article. Clinical Trial.
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial.
Asao T, Saida Y, Watanabe S, Kisohara A, Kishi K, Morita R, Nakagawa T, Tsukita Y, Furuya N, Miyawaki T, Ishikawa N, Yamada T, Tanaka T, Morita S, Kikuchi T, Maemondo M, Kobayashi K; North East Japan Study Group. Asao T, et al. Among authors: yamada t. Lancet Respir Med. 2025 Dec;13(12):1057-1066. doi: 10.1016/S2213-2600(25)00240-1. Epub 2025 Sep 28. Lancet Respir Med. 2025. PMID: 41033335 Clinical Trial.
Exploration of clinical Biomarkers for guiding treatment selection between chemotherapy and combination therapy with Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Mutant NSCLC patients after EGFR-TKI Therapy: The SPIRAL-STEP study.
Morimoto K, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Hata T, Matsumoto S, Honda R, Date K, Chihara Y, Takayama K. Morimoto K, et al. Among authors: yamada t. Lung Cancer. 2025 Mar;201:108447. doi: 10.1016/j.lungcan.2025.108447. Epub 2025 Feb 15. Lung Cancer. 2025. PMID: 39970730
12,578 results
You have reached the last available page of results. Please see the User Guide for more information.